Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 9, 2024
'We're taught green is good': Perspectives on time in range and time in tight range from youth with type 1 diabetes, and parents of youth with type 1 diabetes
Molly L Tanenbaum, Erica Pang, Rachel Tam, et al.
Pediatric Blood & Cancer
|
January 20, 2018
BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma
Julia C Chisholm, Jozef Suvada, Ira J Dunkel, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2025
Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial
Jason J Luke, Katherine Bever, F Stephen Hodi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 6, 2022
Immune contexture of paediatric cancers
Meghna Das Thakur, Carl J Franz, Laura Brennan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2019
Reply to S. Sorscher
Federico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2019
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome
Federico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
The Oncologist
|
March 26, 2014
Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing
Liangxuan Zhang, Liangjing Chen, Sachin Sah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2019
A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer
Robert Piskol, Ling Huw, Ismail Sergin, et al.
Neuro-Oncology
|
February 22, 2023
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908
Ira J Dunkel, François Doz, Nicholas K Foreman, et al.
NPJ Breast Cancer
|
July 20, 2017
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population
Timothy R Wilson, Jianjun Yu, Xuyang Lu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 9, 2024
'We're taught green is good': Perspectives on time in range and time in tight range from youth with type 1 diabetes, and parents of youth with type 1 diabetes
Molly L Tanenbaum, Erica Pang, Rachel Tam, et al.
Pediatric Blood & Cancer
|
January 20, 2018
BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma
Julia C Chisholm, Jozef Suvada, Ira J Dunkel, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2025
Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial
Jason J Luke, Katherine Bever, F Stephen Hodi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 6, 2022
Immune contexture of paediatric cancers
Meghna Das Thakur, Carl J Franz, Laura Brennan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2019
Reply to S. Sorscher
Federico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2019
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome
Federico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
The Oncologist
|
March 26, 2014
Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing
Liangxuan Zhang, Liangjing Chen, Sachin Sah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2019
A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer
Robert Piskol, Ling Huw, Ismail Sergin, et al.
Neuro-Oncology
|
February 22, 2023
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908
Ira J Dunkel, François Doz, Nicholas K Foreman, et al.
NPJ Breast Cancer
|
July 20, 2017
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population
Timothy R Wilson, Jianjun Yu, Xuyang Lu, et al.
Page
of 3